Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle. | J Nephrol | 2023 | 37256539 | PubTator, text mining | PubMed |
| Disease profiles in the Indigenous Australian population are suggestive of a common complement control haplotype. | Infect Genet Evol | 2023 | 37245779 | PubTator, text mining | PubMed |
| Delayed Hematological Remission Predicts Poor Renal Outcome in Children with Atypical Hemolytic Uremic Syndrome. | Indian J Nephrol | 2023 | 37234434 | PubTator, text mining | PubMed |
| Balancing selection on the complement system of a wild rodent. | BMC Ecol Evol | 2023 | 37231383 | PubTator, text mining | PubMed |
| Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers. | Mol Cell Proteomics | 2023 | 37211046 | PubTator, text mining | PubMed |
| Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis. | Front Med (Lausanne) | 2023 | 37206472 | PubTator, text mining | PubMed |
| Plasma proteome perturbation for CMV DNAemia in kidney transplantation. | PLoS One | 2023 | 37205661 | PubTator, text mining | PubMed |
| Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology. | medRxiv | 2023 | 37205413 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
| Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know. | Immunobiology | 2023 | 37187043 | PubTator, text mining | PubMed |
| Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study. | Kidney Int Rep | 2023 | 37180505 | PubTator, text mining | PubMed |
| Short exposure to photo-oxidative damage triggers molecular signals indicative of early retinal degeneration. | Front Immunol | 2023 | 37180103 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis. | Clin Proteomics | 2023 | 37179321 | PubTator, text mining | PubMed |
| HyperSCP: Combining Isotopic and Isobaric Labeling for Higher Throughput Single-Cell Proteomics. | Anal Chem | 2023 | 37167627 | PubTator, text mining | PubMed |
| Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer. | BMC Cancer | 2023 | 37158852 | PubTator, text mining | PubMed |
| Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion. | BMC Nephrol | 2023 | 37147581 | PubTator, text mining | PubMed |
| A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy. | Bioact Mater | 2023 | 37122898 | PubTator, text mining | PubMed |
| Comparative Analysis of Molecular Functions and Biological Role of Proteins from Cell-Free DNA-Protein Complexes Circulating in Plasma of Healthy Females and Breast Cancer Patients. | Int J Mol Sci | 2023 | 37108441 | PubTator, text mining | PubMed |
| Editorial: Updates on the complement system in kidney diseases. | Front Immunol | 2023 | 37090708 | PubTator, text mining | PubMed |
| Proteomic Analysis of Complement Proteins in Glomerular Diseases. | Kidney Int Rep | 2023 | 37069992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=9